My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Vaccimonitor
Print version ISSN 1025-028XOn-line version ISSN 1025-0298
Abstract
CUBA-ROMERO, Yaritza et al. Characterization of clinical isolates of Leptospira for veterinary vaccines. Vaccimonitor [online]. 2016, vol.25, n.1. ISSN 1025-028X.
One of the most important approaches for the development of Leptospira immunogens is to have very well characterized strains by their virulence and which are representative of the circulating serogroups from the clinical and veterinarian point of view. All of this allows to guarantee immunogens capable to protect against the serovars present in the formulation and that affect animals at risk. This paper was carried out from isolations of the causal agent of five autochthonous clinical cases of Leptospira at Holguín, by means of phenotypic conventional methods: growth at 13ºC, in supplemented media with 8-azaguanina and in the presence of sodium chloride. The isolations were also classified until serogroup level by the microaglutination technique. A strain of Ballum serogroup was selected and characterized from these isolations as a vaccinal candidate. The isolations did not show growth at 13ºC, not even when 8-azaguanina (2.25 mg/mL) was added to the culture, while all the strains showed conversion to spherical form in the presence of sodium chloride (1M). The classification of the isolations allowed having two strains belonging to the serogroup Ballum and two to Pomona. The selected strain showed high virulence and pathogenicity in the Syrian Hamster bio model, as well as a good stability in the culture media. Its classification until the serovar level by means of the use of monoclonal antibodies determined that it belonged to the Ballum serovar. The present paper sets for the first-time the bases for novel vaccinal formulations in animals, containing the serogroup Ballum.
Keywords : Leptospira; Ballum; vaccines.